VAI TRÒ CỦA THUỐC SINH HỌC TRONG ĐIỀU TRỊ BỆNH BẠCH CẦU CẤP DÒNG LYMPHO: XU HƯỚNG CÁ THỂ HÓA ĐIỀU TRỊ

Objective: An overview of the role of biologics and the trend towards individualized treatment of acute lymphoblastic leukemia.Methods: This study synthesizes scientific knowledge and perspectives according to PRISMA guidelines, using secondary literature from reputable health organizations and 10 English-language studies analyzed using narrative synthesis.Results: A comprehensive review of 10 studies shows that biologic agents (blinatumomab, inotuzumab ozogamicin, and CAR-T cell therapy) improve the rate of minimal residual disease (MRD) negativity, reaching up to 93%. Combination regimens incorporating tyrosine kinase inhibitors (TKIs) and monoclonal antibodies have opened the way to a chemotherapy-free paradigm as frontline therapy for Philadelphia chromosome-positive (Ph+) ALL, achieving complete remission (CR) rates of 98%. Furthermore, dual-targeting CAR-T technology has been developed to overcome drug resistance mechanisms.Conclusion: Biologic therapies represent a revolutionary advancement and serve as the cornerstone of the modern trend toward personalized treatment of acute lymphoblastic leukemia (ALL). The application of targeted therapies and advanced cellular approaches enables the eradication of leukemic cells at the molecular level, establishing MRD assessment as an important prognostic marker for survival and helping to replace the previous one-size-fits-all chemotherapy regimens.

Authors

Publication Details

Journal
Journal of Clinical Medicine Bach Mai Hospital
Published
2026-11-21
DOI
https://doi.org/10.52322/jocmbmh.156.0201
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

VAI TRÒ CỦA THUỐC SINH HỌC TRONG ĐIỀU TRỊ BỆNH BẠCH CẦU CẤP DÒNG LYMPHO: XU HƯỚNG CÁ THỂ HÓA ĐIỀU TRỊ

Triều Vỉ Võ, Thị Ly Ly Ngọc Vũ, A Nữ Vũ Quỳnh Trịnh, Minh Quang Trần
Journal of Clinical Medicine Bach Mai Hospital
Acute Lymphoblastic Leukemia research
article

VAI TRÒ CỦA THUỐC SINH HỌC TRONG ĐIỀU TRỊ BỆNH BẠCH CẦU CẤP DÒNG LYMPHO: XU HƯỚNG CÁ THỂ HÓA ĐIỀU TRỊ

Triều Vỉ Võ, Thị Ly Ly Ngọc Vũ, A Nữ Vũ Quỳnh Trịnh, Minh Quang Trần
article en

Abstract

Objective: An overview of the role of biologics and the trend towards individualized treatment of acute lymphoblastic leukemia.Methods: This study synthesizes scientific knowledge and perspectives according to PRISMA guidelines, using secondary literature from reputable health organizations and 10 English-language studies analyzed using narrative synthesis.Results: A comprehensive review of 10 studies shows that biologic agents (blinatumomab, inotuzumab ozogamicin, and CAR-T cell therapy) improve the rate of minimal residual disease (MRD) negativity, reaching up to 93%. Combination regimens incorporating tyrosine kinase inhibitors (TKIs) and monoclonal antibodies have opened the way to a chemotherapy-free paradigm as frontline therapy for Philadelphia chromosome-positive (Ph+) ALL, achieving complete remission (CR) rates of 98%. Furthermore, dual-targeting CAR-T technology has been developed to overcome drug resistance mechanisms.Conclusion: Biologic therapies represent a revolutionary advancement and serve as the cornerstone of the modern trend toward personalized treatment of acute lymphoblastic leukemia (ALL). The application of targeted therapies and advanced cellular approaches enables the eradication of leukemic cells at the molecular level, establishing MRD assessment as an important prognostic marker for survival and helping to replace the previous one-size-fits-all chemotherapy regimens.

Journal of Clinical Medicine Bach Mai HospitalVol. 2(156)
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon